Monthly Archives: July 2017

By definition, at a particular point in the process, ill babies are transferred from the care of the team who delivered them into the world to the care of a neonatology team but communication between these two teams of health … Continue reading →

In this study Jeffrey D. Sperling, from the University of California, San Francisco, compared the effectiveness of multiple daily injections (MDI) for controlling women’s insulin levels during their pregnancies with the effectiveness of continuous subcutaneous insulin infusion (CSII). 156 women … Continue reading →

Approximately 8–23% of premature infants develop pulmonary hypertension (PH), and this diagnosis confers a higher possibility of mortality. As a result, professional societies recommend PH screening in premature infants. However, the risk factors for and the outcomes of PH may … Continue reading →

Complications during pregnancy, childbirth and/or the postnatal period may result in the admission of a baby to a neonatal unit (NNU). While the survival and long-term prospects of high-risk infants are enhanced by admission, the enforced separation of the parent … Continue reading →

The use of cord blood in the neonatal screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency is being done with increasing frequency but has yet to be adequately evaluated against the use of peripheral blood sample which is usually employed for confirmation. The … Continue reading →

Retinopathy of prematurity (ROP) still represents one of the leading causes of visual impairment in childhood. Systemic propranolol has proven to be effective in reducing ROP progression in preterm newborns, although safety was not sufficiently guaranteed. On the contrary, topical … Continue reading →

In this study Sarah K. Dotters-Katz, from the University of North Carolina, led a team of researchers looking into the risk factors associated with septic pelvic thrombophlebitis (SPT). Out of 73,087 women who took part in the study 89 (0.1%) … Continue reading →